Jeffrey Tefft, MD | |
2150 Pennsylvania Ave, The Gw Medical Faculty Associates, Nw Washington, DC 20037 | |
(315) 368-3941 | |
Not Available |
Full Name | Jeffrey Tefft |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 8 Years |
Location | 2150 Pennsylvania Ave, Nw Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326572926 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Good Samaritan Hospital Of Suffern | Suffern, NY | Hospital |
St Anthony Community Hospital | Warwick, NY | Hospital |
Bon Secours Community Hospital | Port jervis, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orange Pathology Associates, Pc | 5698664159 | 18 |
Orange Pathology Associates, Pc | 5698664159 | 18 |
News Archive
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Applied Biomics, Inc., a leading Proteomics service provider, is pleased to announce the addition of iTRAQ service (Isobaric Tags for Relative and Absolute Quantitation) to its proteomics line.
Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
Columbia Laboratories, Inc. announced that in a special meeting of stockholders held this morning, stockholders approved the sale of substantially all of Columbia's progesterone related assets to Watson Pharmaceuticals, Inc.. Stockholders also voted to increase the number of authorized shares of Columbia's common stock, $0.01 par value per share, from 100,000,000 to 150,000,000.
› Verified 3 days ago
Entity Name | Orange Pathology Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053355248 PECOS PAC ID: 5698664159 Enrollment ID: O20040312000474 |
News Archive
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Applied Biomics, Inc., a leading Proteomics service provider, is pleased to announce the addition of iTRAQ service (Isobaric Tags for Relative and Absolute Quantitation) to its proteomics line.
Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
Columbia Laboratories, Inc. announced that in a special meeting of stockholders held this morning, stockholders approved the sale of substantially all of Columbia's progesterone related assets to Watson Pharmaceuticals, Inc.. Stockholders also voted to increase the number of authorized shares of Columbia's common stock, $0.01 par value per share, from 100,000,000 to 150,000,000.
› Verified 3 days ago
Entity Name | Westchester Medical Center Advanced Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Applied Biomics, Inc., a leading Proteomics service provider, is pleased to announce the addition of iTRAQ service (Isobaric Tags for Relative and Absolute Quantitation) to its proteomics line.
Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
Columbia Laboratories, Inc. announced that in a special meeting of stockholders held this morning, stockholders approved the sale of substantially all of Columbia's progesterone related assets to Watson Pharmaceuticals, Inc.. Stockholders also voted to increase the number of authorized shares of Columbia's common stock, $0.01 par value per share, from 100,000,000 to 150,000,000.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey Tefft, MD 7821 Stone Rd, Whitesboro, NY 13492-4012 Ph: (315) 368-3941 | Jeffrey Tefft, MD 2150 Pennsylvania Ave, The Gw Medical Faculty Associates, Nw Washington, DC 20037 Ph: (315) 368-3941 |
News Archive
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Applied Biomics, Inc., a leading Proteomics service provider, is pleased to announce the addition of iTRAQ service (Isobaric Tags for Relative and Absolute Quantitation) to its proteomics line.
Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.
An international vaccine symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9 will reflect a dramatic shift in the world of vaccinology, according to Alan Barrett, director of UTMB's Sealy Center for Vaccine Development.
Columbia Laboratories, Inc. announced that in a special meeting of stockholders held this morning, stockholders approved the sale of substantially all of Columbia's progesterone related assets to Watson Pharmaceuticals, Inc.. Stockholders also voted to increase the number of authorized shares of Columbia's common stock, $0.01 par value per share, from 100,000,000 to 150,000,000.
› Verified 3 days ago